Emergence Therapeutics is working on the clinical development of its lead candidate that targets nectin-4

CEPI and Gritstone bio have entered into a deal to develop a candidate for a vaccine against omicron

Scientists have found that the delta variant incubation period can be 3-5 days

Scientists believe that some parts of Psychotria insularum can be used in traditional pharmaceutical production

Infectious mononucleosis experience in childhood is now considered as a factor that increases the risk of multiple sclerosis

A large study has found the increased risk of Parkinson's disease due to seasonal infection

The American regulator has used long-acting corticotropin injections in the treatment of some chronic autoimmune diseases

An antidiabetic drug can help to treat a rare type of brain and spinal cord cancer

A biotech company has designed an innovative enzyme – a recombinant exebacase to destroy staphylococcus aureus

MSD has published Phase II study data suggesting the candidate is effective to treat exacerbations of relapsing multiple sclerosis